NL-OMON51739招募中3 期
Pred Forte® in chronic central serous chorioretinopathy - PICS Trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosis of severe chronic central serous chorioretinopathy that meets the
- •criteria outlined in section 6.1 of protocol
- •- 18 years or older
- •- doesn*t meet any exclusion criteria, is willing to sign the consent form
- •- able to self-administer eye drops.
排除标准
- •- evidence of another retinal diagnoses, such as exudative age-related macular
- •degeneration, suspicion of secondary choroidal neovascularization, polypoidal
- •choroidal vasculopathy, multifocal choroiditis, retinal vascular occlusions,
- •pseudoxanthoma elasticum, amblyopia, and severe myopia (more than *6 dioptres).
- •- women that are breast feeding or pregnant
研究者
相似试验
进行中（未招募）
1 期
Prednisolone eye drop in chronic central serous chorioretinopathy: a randomised clinical trialEUCTR2022-000338-41-NLStichting Radboud universitair medisch centrum40
已完成
1 期
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave AcetateChronic Central Serous ChorioretinopathyNCT00489840Manhattan Eye, Ear & Throat Hospital5
已完成
1 期
Topical Interferon Gamma-1b for Central Serous ChorioretinopathyRetinal DiseaseMacular DiseaseNCT01468337National Eye Institute (NEI)5
已完成
2 期
High-dose Antioxidants for Central Serous ChorioretinopathyCentral Serous ChorioretinopathyNCT00963131Prince of Songkla University60
已完成
不适用
Central Serous Chorioretinopathy: Etiology, Course and PrognosisCentral Serous ChorioretinopathyNCT01378130Medical University of Vienna50